Non-invasive vagus nerve stimulation devices

Non-invasive vagus nerve stimulation (nVNS) devices deliver stimulation to the vagus nerve without surgical implantation. They are under investigation for potential roles in regulating the autonomic nervous system and in conditions such as stress, anxiety, and sleep disturbance.[1]

While interest in these devices has grown, many public resources and reviews are paid advertisements or sponsored content, which may present biased or incomplete information.[2] Peer-reviewed, large-scale clinical studies are limited for many commercially available products.

Classifications

edit

Cervical electrical VNS

edit

Cervical electrical VNS devices deliver transcutaneous electrical impulses to the cervical vagus nerve through the neck.

  • ElectroCore (gammaCore): An FDA-cleared handheld device indicated for the acute treatment of migraine and cluster headaches.[3]
  • TruVaga: A portable cervical stimulator marketed for stress and anxiety reduction; as of 2025, independent peer-reviewed clinical evidence is limited.[4]
  • Pulsetto: A consumer device marketed for relaxation and sleep. As of 2025, it has not been evaluated in peer-reviewed clinical trials. Independent reviewers have reported that Pulsetto used imagery from unrelated scientific studies in its marketing materials, a practice described as misleading or scientifically inappropriate.[5][6][7]
  • TENS devices: Standard transcutaneous electrical nerve stimulation (TENS) units, commonly used for pain, have been adapted experimentally for cervical vagal stimulation, though they are not specifically cleared for this purpose.[8]

Auricular electrical VNS

edit

Auricular electrical stimulation targets the vagus nerve fibers accessible through the outer ear.

  • Alpha-Stim: A device delivering microcurrents via ear-clip electrodes. It has been investigated in small clinical studies for anxiety, insomnia, and depression.[9]
  • Nurosym by Parasym: A wearable auricular neuromodulation device marketed for autonomic regulation. Nurosym is CE marked in Europe as medical device. Parasym has pioneered independent placebo controlled research using its auricular vagal neuromodulation system in cardiovascular conditions,[10][11] long-covid[12][13] and neuroenhancement[14][15] although large-scale validation is currently pending.[16] Parasym also produces a consumer device for the US market called Nuropod, which featured in Bryan Johnson's Netflix documentary "Don't Die: The Man Who Wants to Live Forever".

Mechanical vibration VNS

edit

Devices using mechanical vibration aim to stimulate vagal pathways indirectly via vibratory signals.

  • Apollo Neuro: A wearable that applies low-frequency vibrations to the body. A feasibility study suggested effects on heart rate variability, but further trials are needed.[17]
  • Sensate: A chest-worn device producing infrasonic vibrations, marketed as enhancing vagal tone. Independent peer-reviewed evidence remains limited.[18]

Auricular ultrasound VNS

edit
  • ZenBud (NeurGear): An auricular ultrasound stimulator that applies low-intensity ultrasound to the outer ear. A 2025 peer-reviewed pilot study reported reductions in anxiety-related symptoms, though larger trials are required to establish efficacy.[19]

Criticisms and considerations

edit

While non-invasive vagus nerve stimulation technologies have expanded in consumer markets, many lack robust, independent clinical evidence validating many claims.[20] Most consumer-facing reviews and information sources are financially tied to manufacturers, potentially introducing bias.[21]

Healthcare providers recommend cautious evaluation of claims and consultation with medical professionals before beginning nVNS treatments, particularly for individuals with underlying medical or psychiatric conditions.[22]

See also

edit

References

edit
  1. Yap, J.Y.Y. (2020). "Critical Review of Transcutaneous Vagus Nerve Stimulation: Challenges for Translation to Clinical Practice". Frontiers in Neuroscience. 14 284. doi:10.3389/fnins.2020.00284. PMC 7199464. PMID 32410932.
  2. Farmer, A.D. (2020). "International Consensus Based Review and Recommendations for Minimum Reporting Standards in Clinical Studies of transcutaneous Vagus Nerve Stimulation (tVNS)". Brain Stimulation. 13 (3): 688–700. doi:10.1016/j.brs.2020.01.002. PMID 32289677.
  3. "510(k) Summary: gammaCore Sapphire Non-invasive Vagus Nerve Stimulator" (PDF). FDA Premarket Notification Database.
  4. "Evaluation of a Non-invasive Device for Stress and Anxiety Reduction". ClinicalTrials.gov.
  5. Kummer, Michael (2025). "Pulsetto Review". MichaelKummer.com. Retrieved 10 September 2025.
  6. "Should You Trust Pulsetto? An Objective Look at the Controversial Vagus Nerve Device". Hoolest. 2025. Retrieved 10 September 2025.
  7. "Klajoklio nervo stimuliatorių siūlanti "Pulsetto" pripažino nuplagijavusi klinikinį tyrimą". 15 December 2025.
  8. Clancy, J.A. (2013). "The wonders of the Wanderer: What has vagus nerve stimulation taught us about autonomic control of inflammation?". The Journal of Physiology. 591 (2): 4085–4096. doi:10.1113/jphysiol.2013.254920. PMC 3779107. PMID 23753525.
  9. Barclay, T.H. (2014). "A clinical trial of cranial electrotherapy stimulation for anxiety and comorbid depression". Journal of Affective Disorders. 164: 171–177. doi:10.1016/j.jad.2014.04.029. PMID 24856571.
  10. Stavrakis, Stavros; Stoner, Julie A.; Humphrey, Mary Beth; Morris, Lynsie; Filiberti, Adrian; Reynolds, Justin C.; Elkholey, Khaled; Javed, Isma; Twidale, Nicholas; Riha, Pavel; Varahan, Subha; Scherlag, Benjamin J.; Jackman, Warren M.; Dasari, Tarun W.; Po, Sunny S. (2020). "TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation)". JACC: Clinical Electrophysiology. 6 (3): 282–291. doi:10.1016/j.jacep.2019.11.008. PMC 7100921.
  11. Dasari, Tarun W.; Chakraborty, Praloy; Mukli, Peter; Akhtar, Khawaja; Yabluchanskiy, Andriy; Cunningham, Madeleine W.; Csiszar, Anna; Po, Sunny S. (2023). "Noninvasive low-level tragus stimulation attenuates inflammation and oxidative stress in acute heart failure". Clinical Autonomic Research. 33 (6): 767–775. doi:10.1007/s10286-023-00997-z. PMID 37943335.
  12. "Transcutaneous Auricular Vagus Nerve Stimulation (TVNS) can Reverse the Manifestations of the Long-COVID Syndrome: A Pilot Study". 2021. S2CID 235350729.
  13. Zheng, Z. S.; Simonian, N.; Wang, J.; Rosario, E. R. (2024). "Transcutaneous vagus nerve stimulation improves Long COVID symptoms in a female cohort: A pilot study". Frontiers in Neurology. 15 1393371. doi:10.3389/fneur.2024.1393371. PMC 11097097. PMID 38756213.
  14. Cibulcova, Veronika; Koenig, Julian; Jackowska, Marta; Jandackova, Vera Kr (2024). "Influence of a 2-week transcutaneous auricular vagus nerve stimulation on memory: Findings from a randomized placebo controlled trial in non-clinical adults". Clinical Autonomic Research. 34 (4): 447–462. doi:10.1007/s10286-024-01053-0. PMC 11732881. PMID 39039354.
  15. Geddes, Linda (23 August 2023). "The key to depression, obesity, alcoholism – and more? Why the vagus nerve is so exciting to scientists". The Guardian.
  16. Farmer, A.D. (2020). "International Consensus Based Review and Recommendations for Minimum Reporting Standards in Clinical Studies of transcutaneous Vagus Nerve Stimulation (tVNS)". Brain Stimulation. 13 (3): 688–700. doi:10.1016/j.brs.2020.01.002. PMID 32289677.
  17. Rabin, D. (2022). "Impact of a Wearable Vibrational Neurotechnology on Heart Rate Variability and Sympathetic Nervous System Activity: Feasibility Study". Frontiers in Psychiatry. 13. doi:10.3389/fpsyt.2022.791518 (inactive 1 July 2025).{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link)
  18. Yap, J.Y.Y. (2020). "Critical Review of Transcutaneous Vagus Nerve Stimulation: Challenges for Translation to Clinical Practice". Frontiers in Neuroscience. 14 284. doi:10.3389/fnins.2020.00284. PMC 7199464. PMID 32410932.
  19. Kohler, Izzy; Hacker, Jon; Martin, Ethan (May 1, 2025). "Reduction of Anxiety-Related Symptoms Using Low-Intensity Ultrasound Neuromodulation on the Auricular Branch of the Vagus Nerve: Preliminary Study". JMIR Neurotechnology. 4 e69770. doi:10.2196/69770. PMC 12671299. PMID 41341418.
  20. Yap, J.Y.Y. (2020). "Critical Review of Transcutaneous Vagus Nerve Stimulation: Challenges for Translation to Clinical Practice". Frontiers in Neuroscience. 14 284. doi:10.3389/fnins.2020.00284. PMC 7199464. PMID 32410932.
  21. Farmer, A.D. (2020). "International Consensus Based Review and Recommendations for Minimum Reporting Standards in Clinical Studies of transcutaneous Vagus Nerve Stimulation (tVNS)". Brain Stimulation. 13 (3): 688–700. doi:10.1016/j.brs.2020.01.002. PMID 32289677.
  22. Farmer, A.D. (2020). "International Consensus Based Review and Recommendations for Minimum Reporting Standards in Clinical Studies of transcutaneous Vagus Nerve Stimulation (tVNS)". Brain Stimulation. 13 (3): 688–700. doi:10.1016/j.brs.2020.01.002. PMID 32289677.